Vous êtes sur la page 1sur 3

WHOvaccinepreventablediseases:monitoringsystem.

2016globalsummary
Lastupdated1December2016(dataasof18November2016)

NextoverallupdateJune2017

Selectacountry

SouthSudan

GNI/capita(US$): 7901 Infant(under12months)mortalityrate: 262


Developmentstatus: Leastdeveloped
GDP/capita(US$): 1'8501 Child(under5years)mortalityrate: 392

Populationdatainthousands3

2015 2014 2013 2012 2011 2000 1990 1980


Totalpopulation 12'340 11'911 11'454 10'981 10'510 6'693 5'762 4'701
Births 446 435 423 412 400 286 266 227
Survivinginfants 413 403 391 379 367 255 229 190
Pop.lessthan5years 1'956 1'910 1'855 1'793 1'726 1'193 1'046 846
Pop.lessthan15years 5'193 5'051 4'891 4'717 4'539 3'001 2'549 2'094
Female1549years 2'935 2'820 2'699 2'577 2'456 1'506 1'322 1'079

(ClickforretrospectiveincidencedataforSouthSudan)
Numberofreportedcases

Diphtheria 9 0 _ _ _ _ _ _
Japaneseencephalitis 0 0 _ _ _ _ _ _
Measles 878 441 525 1'952 1'256 _ _ _
Mumps 0 0 _ _ _ _ _ _
Pertussis 3 0 _ _ _ _ _ _
Polio* 0 2 0 0 _ 0 _ _
Rubella 47 0 _ 20 _ _ _ _
Rubella(CRS) 0 0 _ _ _ _ _ _
Tetanus(neonatal) 0 0 25 48 45 _ _ _
Tetanus(total)** 4 0 32 _ _ _ _ _
Yellowfever 0 0 _ 0 128 _ _ _
*Polioreferstoallpoliocases(indigenousorimported),includingpoliocasescausedbyvaccinederivedpolioviruses(VDPV).Fordesagregateddatapleaseclickonthishyperlink:https://extranet.who.int/polis/public/CaseCount.aspx
itdoesnotincludecasesofvaccineassociatedparalyticpolio(VAPP)andcasesofnonpolioacuteflaccidparalysis[AFP]).
**NeonatalTetanusandTotalTetanuscasesequalitymaybetheresultfromalackofnonNeonatalTetanussurveillancesystem.

Percentagetargetpopulationvaccinatedbyantigen Hoveringoveranantigenrevealsitsfullerdefinition

Mostrecentcoveragesurvey 4 Officialcountryestimates5
(ClickforretrospectivecoverageestimatesdataforSouthSudan)
Vaccine year result method %cardseen
BCG 2011 75 EPI 51 58 61 64 73 57 _ _ _
DTP1 2011 79 EPI 51 60 72 60 70 58 _ _ _
DTP3 2011 55 EPI 51 50 58 56 68 46 _ _ _
DTP4 _ _ _ _ _ _ _ _
IPV1 3 _ _ _ _ _ _ _
HepB_BD _ _ _ _ _ _ _ _
HepB3 55 _ _ _ _ _ _ _
Hib3 55 _ _ _ _ _ _ _
JapEnc _ _ _ _ _ _ _ _
MCV1 70 52 55 70 64 _ _ _
MCV2 _ _ _ _ _ _ _ _
PCV1 _ _ _ _ _ _ _ _
PCV3 _ _ _ _ _ _ _ _
Pol3 2011 59 EPI 51 55 58 56 68 46 _ _ _
Rota1 _ _ _ _ _ _ _ _
RotaC _ _ _ _ _ _ _ _
RCV1 _ _ _ _ _ _ _ _
TT2plus 2011 65 EPI 51 28 45 41 50 61 _ _ _
PAB _ _ _ _ _ _ _ _
VAD1 _ _ _ _ _ _ _ _
YFV _ _ _ _ _ _ _ _
indicatesthatmorethan1surveyoccurredthatyear. *indicatesthecountryreportedabove100%coverage.

Nextupdate:MidJuly2017 WHOUNICEFestimates6
(ClickforfullretrospectiveWHOUNICEFcoverageestimatesdataforSouthSudan)
BCG 43 46 52 62 75 _ _ _
DTP1 49 49 57 71 79 _ _ _
DTP3 31 39 45 59 61 _ _ _
HepB3 31 _ _ _ _ _ _ _
HepB_BD _ _ _ _ _ _ _ _
Hib3 31 _ _ _ _ _ _ _
IPV1 3 _ _ _ _ _ _ _
MCV1 20 22 30 52 62 _ _ _
MCV2 _ _ _ _ _ _ _ _
PAB 68 64 64 64 64 _ _ _
PCV3 _ _ _ _ _ _ _ _
Pol3 41 44 50 64 66 _ _ _
RCV1 _ _ _ _ _ _ _ _
RotaC _ _ _ _ _ _ _ _

Proportionof / Greaterorequalto90% 23
Numberofdistrictsinthecountry 80 districtsreporting | From80to89% 16
DTP3coverage: | From50to79% 18
%ofcoveragereportsreceivedatnational \ Lessthan50% 38
81
levelvsnumberofreportsexpected Proportionofdistricts
5
notreportingDTP3coverage

ImmunizationSchedule(2015orlatestavailable) Hoveringoveranantigenrevealsitsfullerdefinition
Vaccine Schedule Entirecountry Comment
BCG birth Yes
DTwPHibHepB 6,10,14weeks Yes
IPV 14weeks Yes FromSeptember2015
Measles 9months Yes
OPV birth6,10,14weeks Yes
TT Firstcontact+1,+6months+1,+1year Yes 1549years

Immunizatonindicators

Indicator Expectedanswer 2015 2014 2013 2012 2011 2010 2009

Planningandmanagement

HasthecountryaMultiYearPlan(MYP)forimmunization? Yes/No/NR Yes Yes Yes Yes Yes


WhatyearsdoestheMYPcover? number 20122016 20122016 20122016 20122016 2012to2016
Nofdistrictswithmicroplansthatincludeactivitiestoraiseimmunizationcoverage number 43 43 80 80 79

Systemperformance

TotalNdistrictsincountry number 80 80 80 80 79
NdistrictswithDTP3coverage>=80% number 31 20 18 33 36
%ofdistrictswithDTP3coverage>=80% From0to100% 39 25 23 41 46
Ndistrictswithmeasles(MCV1)coverage>=95% number 20 28 27 36 45
%ofdistrictswithMCV1coverage>=95% From0to100% 25 35 34 45 57

Safety

Hasthecountryavaccineadverseeventsreviewcommittee? Yes/No/NR/ND No No No No
Isthereanationalsystemtomonitoradverseeventsfollowingimmunization(AEFI)? Yes/No/NR No No No No

Finance

Immunizationexpenditurefinanced,usingGovernmentfunds? From0to100% 11 1 5

NationalImmunizationAdvisoryMechanism
NationalImmunizationAdvisoryMechanism

Hasthecountryastandingtechnicaladvisorygrouponimmunization(NITAG)? Yes/No/NR Yes Yes Yes No No

Sources
1"The2016WorldBankDevelopmentIndicatorsOnline",GDPpercapitaisPPPadjusted.
2WorldHealthStatistics2016,datafor2015
3"UnitedNations,PopulationDivision.TheWorldPopulationProspectsthe2015revision".NewYork,2016.
4UNICEF/WHOsurveydatabase
5Ifnoofficialestimateisavailable,theadministrativecoverageisreported.'*'indicatescoverageover99.5%.
6WHOUNICEFestimates.

Employment|OtherUNSites|Search|Suggestions|RSS|Privacy
WorldHealthOrganization2017.Allrightsreserved

Vous aimerez peut-être aussi